Last reviewed · How we verify
NCT06322511: DFG II
Dialogical Family Guidance PostDoc Study
NA trial testing Dialogical Family Guidance (DFG) in Family Dynamics in 50 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Tampere University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 2 January 2024 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Dialogical Family Guidance (DFG)
Conditions studied
- Family Dynamics — all drugs for Family Dynamics →
- Family Relations — all drugs for Family Relations →
- Family Support — all drugs for Family Support →
Sponsor
Tampere University
Who can join
Adults 4 to 13, any sex, with Family Dynamics or Family Relations. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This new family intervention, called Dialogical Family Guidance (DFG) is developed to target family needs especially in families with a child with neurodevelopmental disorders. PhD study showed, that this intervention is functioning with this target group. Participants (families) experienced that they got information, guidance to ordinary life and that the DFG-therapists were listening to them and above all, helping with individual problems and questions. DFG include six meetings and professionals need to attend on a 3-day long education before using this intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06322511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Family Dynamics
Currently open trials in the same condition.
- NCT06481631 — Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare · NA · recruiting
Other Tampere University trials
Trials by the same sponsor.
- NCT05786001 — Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia · recruiting
- NCT07131371 — Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions · active not recruiting
- NCT05766202 — The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial · NA · completed
- NCT05626543 — The Effect of Mindfulness-based Cognitive Behavior Therapy on Occupational Stress Management · NA · completed
- NCT04424511 — Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06322511 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tampere University
- Last refreshed: 21 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06322511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing